samedan logo

 
 
spacer
home > news
INDUSTRY NEWS AND PRESS RELEASES
 

The biotech company baseclick GmbH launched a new and highly efficient method for SARS-CoV-2 mutation analysis

The rapid spread of the newly emerging SARS-CoV-2 virus variant B.1.1.7 in Great Britain and other countries shows changes in the genome of the SARS-CoV-2 virus can lead to new biological properties. More>>

 
email info@baseclick.eu
web www.baseclick.eu
email baseclick GmbH Floriansbogen 2-4 D-82061 Neuried (Munich), Germany
 

Join Us In A New Free Webinar by Qloud

Our experience in qualifications has allowed us to identify the necessary improvements for the resolution of data integrity GAPs, and process optimization in regulated environments. More>>

 
phone +34 915 734 206
email we.are@qloudapp.com
web www.qloudapp.com
email Carretera de Fuencarral, 22. 28108 Alcobendas (Madrid)
 

PHASTAR Announces Investment by Charterhouse Capital Partners

Funding will Support Expansion of Statistics and Data Science Services and Geographic Reach

PHASTAR, a specialist biometrics clinical research organization (CRO) for clinical trials, announces an investment made by Charterhouse Capital Partners LLP, a long-established European private equity firm, which will support PHASTAR’s growth in biometrics and geographic expansion. Charterhouse is making its investment in partnership with PHASTAR’s Founder and CEO Kevin Kane, who remains a significant shareholder in the business. Kevin and the existing management team will continue to run, manage and operate the business on a day-to-day basis. More>>

 
phone +44 (0)20 7183 7062
email tellmemore@phastar.com
web www.phastar.com
email Unit 2, 2A Bollo Ln, Chiswick, London W4 5LE
 

Calyx Supports Breakthrough Therapy Approvals for Oncology Treatments

Calyx Medical Imaging and other eClinical services provide critical support for clinical development programs to deliver much-needed therapies to market

Calyx, the eClinical and regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced that its Medical Imaging and other eClinical solutions supported half of the oncology treatments approved by the FDA as Breakthrough Therapies in the past two years. More>>

 
web www.calyx.ai/
 

BIOGEN TO LAUNCH PIONEERING STUDY TO DEVELOP DIGITAL BIOMARKERS OF COGNITIVE HEALTH USING APPLE WATCH AND IPHONE

January 11, 2021 at 7:30 AM EST

The study aims to identify digital biomarkers to help monitor cognitive performance and health including potentially detecting mild cognitive impairment, an early indicator of certain forms of dementia such as Alzheimer’s disease Cognitive health — the ability to think clearly, to learn and to remember — is an indicator of brain health and important to performing daily activities More>>

 
phone +44 1628 501 000
email ukreception@biogen.com
web https://www.biogen.com/
email Innovation House, 70 Norden Road, Maidenhead, Berkshire SL6 4AY
 

EQRx Scales Disruptive Model of Important New Medicines at Lower Prices with $500M Series B Financing

Funding accelerates development of late-stage cancer therapies, pipeline expansion and business growth Syndicate includes all Series A investors, preeminent life science and generalist funds, and market-leading health systems and payers More>>

 
email info@EQRx.com
web www.eqrx.com
 

Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases

Funding accelerates development of late-stage cancer therapies, pipeline expansion and business growth Syndicate includes all Series A investors, preeminent life science and generalist funds, and market-leading health systems and payers More>>

 
phone 781.419.6900
email info@x-chemrx.com
web www.x-chemrx.com
email 100 Beaver Street Waltham, MA 02453
 

3P innovation Announces Transition to Employee Ownership

Award-winning, UK based engineering and process automation company, 3P innovation Ltd, is proud to announce that it is now an employee-owned company. This transition has been taken to secure its long-term future, for the benefit of customers and employees alike. More>>

 
phone 01926 408933
email enquiries@3pinnovation.com
email Tournament Fields Business Park, Bosworth Avenue, Warwick CV34 6NH
 

Loftware and NiceLabel Combine, Extend Global Leadership in Enterprise Labeling and Artwork Management

Portsmouth, NH — January 12, 2021 – Loftware, Inc., the global leader in Enterprise Labeling & Artwork Management Solutions and NiceLabel, a leading developer of label management systems today announced that they are combining under the Loftware corporate umbrella. This union gives customers and partners an expanded choice of solutions, while providing enhanced labeling capabilities and the benefits of greater investment in cloud-based solutions and technologies. It also brings together 60 years of combined expertise in solving labeling challenges for companies of all sizes throughout a wide range of industries across the globe. More>>

 
phone +386 4 280 50 00
email info@nicelabel.com
web https://www.nicelabel.com/
email Poslovna cona A 2, SI-4208 Šenčur
 

Novasep to sell its chromatography equipment division to Sartorius

06 Jan 2021 • A disposal aligned with Novasep’s core strategy • An opportunity for Novasep’s chromatography equipment division to accelerate its growth by joining an established leader in the sector More>>

 
phone +33 3 83 49 71 00
email Novasep@novasep.com
web www.novasep.com
email 81 Boulevard de la Moselle, 54340 Pompey, France
 
 
spacer
News and Press Releases

Peli BioThermal to Present at LogiPharma Europe

Peli BioThermal, the global name in temperature controlled packaging, will be attending this year’s virtual LogiPharma Europe event and highlight how products have been adapted to meet the rising requirements of the pharmaceutical sector’s rapid response to the global pandemic.
More info >>


White Papers

Future-proofing serialization solutions: the importance of strong level 3 capabilities

Adents

The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now. Around the world – in Europe and Asia in particular – disparate track and trace practices are incrementally moving toward a global standard that will, undoubtedly, be more stringent than today’s differing benchmarks. How can companies manage this transformation with the greatest degree of success while also minimizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation
More info >>

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement